Bard
This article was originally published in The Gray Sheet
Executive Summary
Appoints Gerald Messerschmidt, MD, to the newly created post of vice president, scientific affairs. Messerschmidt, 43, will have company-wide responsibility for "medical and clinical affairs, regulatory affairs, quality assurance and environmental health and safety," the firm states in a Jan. 12 announcement. Bard agreed to create such a post under a deal reached in October settling numerous criminal and civil charges related to the firm's USCI angioplasty operations ("The Gray Sheet" Oct. 18, p. 3). The new exec, who will answer to President and Chief Operating Officer William Longfield, most recently served as VP, medical and regulatory affairs at Princeton-based DNX Corp